2 July, 2014

ESHRE 30th Annual Meeting, Munich, Germany

Munich, Germany, July 2, 2014 –Transmed Pharma has concluded todayits participation at the ESHRE Annual Meeting held in Munich, with attendees from all over the world including doctors and embryologists from the West Bank and the Gaza Strip. IBSA’s Satellite Symposium this year focused on ‘Birth Defects Revisited: Causes and Outcome’. Chaired by Pier Giorgio Crosignani (Milan, Italy) and Klaus Diedrich (Luebek, Germany), the Symposium included lectures on Newborn Health and Oocyte Legacy by Dr. David F. Albertini (Kansas City, USA, Outcomes from Large ART Databases in the Nordic Countries by Dr. Arne Sunde (Trondheim, Norway), and International Registration of Birth Defects by Professor Maryse Bonduelle (Brussels, Belgium).

ESHRE stands for the European Society of Human Reproduction and Embryology, whose mission is to promote interest in, and understanding of, reproductive biology and medicine. ESHRE collaborates globally and advocates universal improvements in scientific research and harmonization in clinical practice. It also provides guidance that enhances safety and quality assurance in clinical and laboratory procedures. ESHRE’s activities include teaching, training, and professional accreditations. The ESHRE Annual Meeting is held at a different city in Europe each year.

Please click here for more information.

Back Next